
循環器医療のデジタル未来に向けた、あと一歩とは
2025年には、高血圧や高コレステロールなど心血管疾患のリスクを高める状態を含む、心血管疾患による死亡者が2,000万人を超えると予測されています。また、2050年までには、心臓病など循環器系疾患の有病率は90%増加する見込み。死亡者数は3,500万人に達し、米国だけでも、心血管リスク要因に関連する医療費が同期間に3倍に膨れ上がると予測されています。
Julia Strandberg is the Executive Vice President and Chief Business Leader of Connected Care and a Royal Philips Executive Committee member.
Passionate about helping patients and the community by creating access to healthcare, Julia understands how to deliver in the global healthcare ecosystem, with expertise in software, informatics, and monitoring, and brings extensive experience in developing and commercializing medical technologies.
Julia represents Philips on the AdvaMed Digital Health Board, which focuses on digital health and AI, platformization, cybersecurity, and reimbursement. She is also a member of MedtechWOMEN, among other organizations, and the Executive sponsor and representative for the Health Systems Marketing Leadership Council and the Marketing CoEs.
To address the need to connect patient care, Julia oversees several strategic partnerships with top health systems to bridge the gaps in patient care while continuing to uncover ways to innovate for better outcomes.
Before joining Philips, Julia was the Chief Commercial Officer at Pear Therapeutics, where she led the commercial team to build, launch, and grow the prescription digital therapeutics market and helped the organization go public in December 2021. Before this, Julia led a healthcare business consulting firm focused on driving growth. She also worked at Medtronic for several years, conducting a global informatics and monitoring business. Earlier in her career, Julia worked at Covidien Respiratory & Monitoring Solutions, which was acquired by Medtronic, and at 3M.
Julia holds an MBA from the University of Minnesota Carlson School of Management and a bachelor’s degree in chemical engineering from Purdue University. She has been married to her husband Glen for 20 years, has a dog named Edison, and is a former competitive swimmer and marathoner.
Follow Julia: https://www.linkedin.com/in/julia-m-strandberg/
2025年には、高血圧や高コレステロールなど心血管疾患のリスクを高める状態を含む、心血管疾患による死亡者が2,000万人を超えると予測されています。また、2050年までには、心臓病など循環器系疾患の有病率は90%増加する見込み。死亡者数は3,500万人に達し、米国だけでも、心血管リスク要因に関連する医療費が同期間に3倍に膨れ上がると予測されています。
In 2025, more than 20 million people will die from cardiovascular disease and conditions like high blood pressure and high cholesterol that increase its risk. By 2050, heart disease preva...